Q, Z., G, C., H, W., J, C., & X, H. (2026). Diagnostic Accuracy of Anti-factor Xa Activity, PT, and APTT for Clinically Relevant Rivaroxaban Levels in Older AF Patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 32, 10760296261469286. https://doi.org/10.1177/10760296261469286
Chicago Style (17th ed.) CitationQ, Zhao, Chen G, Wang H, Chen J, and Hu X. "Diagnostic Accuracy of Anti-factor Xa Activity, PT, and APTT for Clinically Relevant Rivaroxaban Levels in Older AF Patients." Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 32 (2026): 10760296261469286. https://doi.org/10.1177/10760296261469286.
MLA (9th ed.) CitationQ, Zhao, et al. "Diagnostic Accuracy of Anti-factor Xa Activity, PT, and APTT for Clinically Relevant Rivaroxaban Levels in Older AF Patients." Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, vol. 32, 2026, p. 10760296261469286, https://doi.org/10.1177/10760296261469286.